<DOC>
	<DOCNO>NCT02976675</DOCNO>
	<brief_summary>To evaluate safety efficacy PEG Somatropin Injection treatment child growth hormone deficiency , well study feasibility extend dose interval ( per two week ) PEG Somatropin Injection .</brief_summary>
	<brief_title>Pegylated Somatropin ( PEG Somatropin ) Treatment Children With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Subjects diagnose GHD start treatment , accord medical history , clinical symptom sign , GH provocation test image examination : 1 . According statistical height data physical development Chinese child nine city 2005 , height low 3rd percentile growth curve age , sex normal child ; 2 . Height velocity ( HV ) ≤5.0 cm / yr ; 3 . GH provocative test ( two drug different mechanism action ) confirm plasma GH peak &lt; 10.0 ng / ml ; 4. bone age girl≤9 year old , Boy≤10 year old , bone age one year later actual age , actual age bone age ≥ 1 year ; Before puberty ( Tanner I stage ) , age≥3 year old , male female ; Subjects receive hormone therapy within 6 month ; Subjects willing able cooperate complete schedule visit , treatment plan laboratory test procedure , sign inform consent . Dysfunction liver kidney ( ALT &gt; 2 time upper limit normal , Cr &gt; upper limit normal ) ; Patients positive hepatitis B cantibody ( HBcAb ) , hepatitis B surface antigen ( HBsAg ) hepatitis B e antigen ( HBeAg ) ; Patients know hypersensitivity PEG Somatropin Somatropin component study product ; Patients severe cardiopulmonary hematological disease , current past history malignant tumor , immunodeficiency disease , mental disease ; Potential cancer patient ( family history ) ; Patients diabetic ; Patients growth disorder , Turner 's syndrome , sexual physical delayed puberty , Laron syndrome , growth hormone receptor deficiency , girl slowly grow rule chromosomal abnormality ; Patients congenital bone dysplasia scoliosis ; Subjects take part clinical trial study 3 month ; Other condition investigator preclude enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>